Viroccinum
Generic Name: viroccinum
Brand Names:
Viroccinum
To reduce the duration and severity of flu-like symptoms
Overview
To reduce the duration and severity of flu-like symptoms
Uses
Temporarily relieves flu-like symptoms such as: body aches Headache fever chills fatigue
Dosage
Directions Adults and children 2 years of age and older: Dissolve entire contents of one tube in the mouth every 6 hours, up to 3 times a day Children under 2 years of age: Ask a doctor.
Side Effects
Stop use and ask a doctor if symptoms persist for more than 3 days or worsen. If pregnant or breast-feeding, ask a health professional before use.
Interactions
Warnings Ask a doctor before use in children under 2 years of age.
Warnings
Warnings Warnings Ask a doctor before use in children under 2 years of age.
Storage
Other information do not use if the tamper evident seal on the flaps is broken or missing or if the tray foil is broken. each 0.04 oz. dose (1g) contains 1 g of sugar store at 68˚F to 77˚F (20˚C to 25˚C) Questions or comments? Call (866) 254-3900, 9 am-5 pm EST.
Frequently Asked Questions
What is Viroccinum used for?▼
Temporarily relieves flu-like symptoms such as: body aches Headache fever chills fatigue
What are the side effects of Viroccinum?▼
Stop use and ask a doctor if symptoms persist for more than 3 days or worsen. If pregnant or breast-feeding, ask a health professional before use.
What are the important warnings for Viroccinum?▼
Warnings Warnings Ask a doctor before use in children under 2 years of age.
Related Medications
Joint Support
joint support
Al-Inflam Assist the body in its response to injury, infection and allergy.
Mavorixafor
mavorixafor
CXC Chemokine Receptor 4 Antagonist [EPC]
11 DESCRIPTION Mavorixafor is an orally bioavailable CXC Chemokine Receptor 4 (CXCR4) antagonist [see Clinical Pharmacology (12.1) ] . The chemical name of the active ingredient, mavorixafor, is N 1 -(1 H -benzimidazol-2-ylmethyl)- N 1 -[(8 S )-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine. It has a molecular formula of C 21 H 27 N 5 and a molecular weight of 349.48 g/mol. Mavorixafor is of the S configuration and its structural formula is provided in Figure 1.
Donepezil Hydrochloride
donepezil hydrochloride
Indicated for the treatment of dementia of the Alzheimer's type. Efficacy has been demonstrated in patients with mild, moderate, and severe Alzheimer's Disease.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.